Bill
AB 837
Overview: AB 837 is a bill related to the drug ketamine, introduced on February 19, 2025 and currently in committee with a "held under submission" status.Purpose and Intent: The in
Overview: AB 837 is a bill related to the drug ketamine, introduced on February 19, 2025 and currently in committee with a "held under submission" status.
Purpose and Intent: The intent of this bill is to address concerns around the use and regulation of ketamine, a drug with both medical and recreational applications.
Key Provisions:
- Establishes new requirements for the prescription, distribution, and administration of ketamine
- Imposes stricter controls on the possession and use of ketamine outside of medical settings
- Increases penalties for the illegal manufacture, sale, or possession of ketamine
Affected Parties and Impacts:
- Patients who rely on ketamine for medical treatment
- Healthcare providers who prescribe or administer ketamine
- Individuals who use ketamine recreationally or illegally
- Law enforcement agencies responsible for enforcing ketamine regulations
Procedural and Timeline Considerations:
The bill is currently being held in committee, indicating it is still under consideration and review. Further action, amendments, or a vote on the bill's passage are pending.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
